Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof

US8809325B2 · kind B2 · utility

Assignee

• Sanofi · FR

Inventors

• Thomas Boehme · Gerolzhofen, DE
• Kurt Ritter · Heidelberg, DE
• Christian Engel · Frankfurt am Main, DE
• Torsten Haack · Frankfurt am Main, DE
• Stefan Guessregen · Frankfurt am Main, DE
• Georg Tschank · Frankfurt am Main, DE

Key dates

• Filing date: Mar 7, 2012
• Grant date: Aug 19, 2014
• Expiry date: Mar 7, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D291/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed is a benzyl-oxathiazine derivative, as shown in Formula I, the derivative being substituted with adamantane or noradamantane:the variables of which are as described herein; also disclosed is a method of preparation and use of same.